The underlying molecular mechanism of apolipoprotein E polymorphism - Relationships to lipid disorders, cardiovascular disease, and Alzheimer's disease

被引：37

作者：

Contois, JH ^{[1
]}

Anamani, DE ^{[1
]}

Tsongalis, GJ ^{[1
]}

机构：

[1] HARTFORD HOSP, DEPT PATHOL & LAB MED, HARTFORD, CT 06102 USA

来源：

CLINICS IN LABORATORY MEDICINE | 1996年 / 16卷 / 01期

关键词：

D O I：

10.1016/S0272-2712(18)30290-7

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

Apolipoprotein E (apo E) polymorphism has important clinical correlates, including disorders of Lipoprotein metabolism and atherosclerosis. This article provides a detailed methodology for apo E genotyping and discusses the link between apo E genotype and type III hyperlipoproteinemia, coronary heart disease (CHD), stroke, and Alzheimer's disease (AD). Although apo E genotype appears to provide significant information concerning the genetic component of CHD and AD risk, more research is needed before genotyping can be recommended as a routine screening tool. The data so far, however, implicate apo E as a major component of the genetic basis of cardiovascular disease and AD.

引用

页码：105 / +

页数：1

共 109 条

[1] THE LDL RECEPTOR RELATED PROTEIN, LRP, IS AN APOLIPOPROTEIN-E-BINDING PROTEIN
BEISIEGEL, U
WEBER, W
IHRKE, G
HERZ, J
STANLEY, KK
[J]. NATURE, 1989, 341 (6238) : 162 - 164
[2] BOERWINKLE E, 1991, AM J HUM GENET, V49, P1145
[3] BOERWINKLE E, 1988, AM J HUM GENET, V42, P104
[4] THE USE OF MEASURED GENOTYPE INFORMATION IN THE ANALYSIS OF QUANTITATIVE PHENOTYPES IN MAN .2. THE ROLE OF THE APOLIPOPROTEIN-E POLYMORPHISM IN DETERMINING LEVELS, VARIABILITY, AND COVARIABILITY OF CHOLESTEROL, BETA-LIPOPROTEIN, AND TRIGLYCERIDES IN A SAMPLE OF UNRELATED INDIVIDUALS
BOERWINKLE, E
VISVIKIS, S
WELSH, D
STEINMETZ, J
HANASH, SM
SING, CF
[J]. AMERICAN JOURNAL OF MEDICAL GENETICS, 1987, 27 (03): : 567 - 582
[5] A RECEPTOR-MEDIATED PATHWAY FOR CHOLESTEROL HOMEOSTASIS
BROWN, MS
GOLDSTEIN, JL
[J]. SCIENCE, 1986, 232 (4746) : 34 - 47
[6] THE RESPONSE TO LOVASTATIN TREATMENT IN PATIENTS WITH HETEROZYGOUS FAMILIAL HYPERCHOLESTEROLEMIA IS MODULATED BY APOLIPOPROTEIN-E POLYMORPHISM
CARMENA, R
ROEDERER, G
MAILLOUX, H
LUSSIERCACAN, S
DAVIGNON, J
[J]. METABOLISM-CLINICAL AND EXPERIMENTAL, 1993, 42 (07): : 895 - 901
[7] RAPID AND SAFE DETERMINATION OF HUMAN APOLIPOPROTEIN-E GENOTYPES BY MINIATURIZED SDS-PAGE IN NON-INSULIN-DEPENDENT DIABETES-MELLITUS
CLAVEL, C
DURLACH, A
DURLACH, V
BIREMBAUT, P
[J]. JOURNAL OF CLINICAL PATHOLOGY, 1995, 48 (04) : 295 - 299
[8] COBB MM, 1991, CIRCULATION, V86, P145
[9] GENE DOSE OF APOLIPOPROTEIN-E TYPE-4 ALLELE AND THE RISK OF ALZHEIMERS-DISEASE IN LATE-ONSET FAMILIES
CORDER, EH
SAUNDERS, AM
STRITTMATTER, WJ
SCHMECHEL, DE
GASKELL, PC
SMALL, GW
ROSES, AD
HAINES, JL
PERICAKVANCE, MA
[J]. SCIENCE, 1993, 261 (5123) : 921 - 923
[10] PREVALENCE OF APOLIPOPROTEIN-E PHENOTYPES IN ISCHEMIC CEREBROVASCULAR-DISEASE - A CASE-CONTROL STUDY
COUDERC, R
MAHIEUX, F
BAILLEUL, S
FENELON, G
MARY, R
FERMANIAN, J
[J]. STROKE, 1993, 24 (05) : 661 - 664

← 1 2 3 4 5 6 7 8 9 10 →